Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017
June 20, 2017 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 20, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CEO Oliver Peoples, Ph.D., will be presenting today at BIO 2017 on a panel entitled:...
Yield10 Bioscience Submits “Am I Regulated?” Letter to USDA-APHIS BRS for Genome-Edited Camelina
June 15, 2017 08:45 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 15, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has submitted an “Am I Regulated?” letter to USDA-APHIS’s Biotechnology Regulatory...
Yield10 Bioscience to Present at the Marcum Microcap Investor Conference
June 14, 2017 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that Oliver Peoples, Ph.D., President and Chief Executive Officer, will present at the Marcum...
Yield10 Bioscience Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
June 13, 2017 10:45 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 13, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has received a letter from The NASDAQ Stock Market LLC notifying the Company that it...
Yield10 Bioscience Starts Field Tests of Novel Yield Trait Gene C3003 in Oilseed Crops Camelina and Canola
June 07, 2017 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced that planting has been completed at study sites in Canada for field tests to evaluate the...
Yield10 Bioscience Announces 1-for-10 Reverse Stock Split
May 26, 2017 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 26, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it will effect a 1-for-10 reverse stock split of its common stock, following stockholder...
Yield10 Bioscience Announces First Quarter 2017 Financial Results
May 11, 2017 16:05 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 11, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three months ended March 31, 2017.Yield10 Bioscience kicked off the...
Yield10 Bioscience to Host Webcast of its First Quarter 2017 Conference Call
April 26, 2017 09:01 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., April 26, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its first quarter 2017 financial results and host a...
Yield10 Bioscience Outlines Plans for Spring 2017 Field Tests of Novel Yield Trait Gene C3003 in Camelina and Canola
March 13, 2017 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 13, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today outlined plans for its Spring 2017 field tests of the novel yield trait gene C3003 in Camelina and...
Yield10 Bioscience Reports Promising Greenhouse Results for Second Generation C3003 Trait in Camelina
March 09, 2017 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced greenhouse results in its model Camelina system showing that its second generation novel...